Even though IDH mutant tumors are generally associated with a favorable prognosis, few studies show that the IDH mutant GA may be associated with a worse clinical outcome and shorter survival than IDH mutant Astrocytomas, even when the tumor grades are the same [19,20]. This evidence concerns the gene IDH1 and neoplasm.